HCA Healthcare, Inc. financial data

Symbol
HCA on NYSE
Industry
Services-General Medical & Surgical Hospitals, NEC
Location
One Park Plz, Nashville, TN
Fiscal year end
December 31
Former names
HCA Holdings, Inc. (to 5/5/2017), HCA INC/TN (to 11/24/2010), HCA THE HEALTHCARE CO (to 5/21/2001), HCA-THE HEALTHCARE CO (to 2/14/2001), COLUMBIA HCA HEALTHCARE CORP (to 5/19/2000), COLUMBIA HCA HEALTHCARE CORP/ (to 2/16/2000), COLUMBIA HEALTHCARE CORP (to 3/1/1994)
Latest financial report
10-K - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -7.12%
Quick Ratio 12.6 % -27%
Return On Equity 583 % -41.3%
Return On Assets 9.88 % +2.28%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 248M shares -6.11%
Common Stock, Shares, Outstanding 250M shares -5.86%
Entity Public Float 60.4B USD -1.24%
Weighted Average Number of Shares Outstanding, Basic 259M shares -5.07%
Weighted Average Number of Shares Outstanding, Diluted 262M shares -5.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 70.6B USD +8.67%
General and Administrative Expense 421M USD +19.3%
Costs and Expenses 62.1B USD +8.41%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.52B USD +10.6%
Income Tax Expense (Benefit) 1.87B USD +15.5%
Net Income (Loss) Attributable to Parent 5.76B USD +9.88%
Earnings Per Share, Basic 22.3 USD/shares +15.7%
Earnings Per Share, Diluted 22 USD/shares +16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.93B USD +107%
Accounts Receivable, after Allowance for Credit Loss, Current 10.8B USD +7.96%
Inventory, Net 1.74B USD -14%
Other Assets, Current 1.99B USD -1.04%
Assets, Current 16.4B USD +9.96%
Property, Plant and Equipment, Net 29.4B USD +6.13%
Operating Lease, Right-of-Use Asset 2.13B USD -3.44%
Other Assets, Noncurrent 230M USD +25%
Assets 59.5B USD +5.87%
Accounts Payable, Current 4.28B USD +1.02%
Liabilities, Current 15.2B USD +19.9%
Operating Lease, Liability, Noncurrent 1.86B USD -2.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -387M USD +8.94%
Retained Earnings (Accumulated Deficit) -2.12B USD -56.4%
Stockholders' Equity Attributable to Parent -2.5B USD -40.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 555M USD -47.6%
Liabilities and Equity 59.5B USD +5.87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.47B USD +36.9%
Net Cash Provided by (Used in) Financing Activities -1.22B USD -67.7%
Net Cash Provided by (Used in) Investing Activities -903M USD +21.5%
Common Stock, Shares Authorized 1.8B shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 349M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.93B USD +107%
Interest Paid, Excluding Capitalized Interest, Operating Activities 538M USD -6.27%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 2.21B USD -2.65%
Payments to Acquire Property, Plant, and Equipment 1.12B USD -6.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.8B USD +9.25%
Lessee, Operating Lease, Liability, to be Paid 3.17B USD -2.34%
Property, Plant and Equipment, Gross 62.5B USD +6.77%
Operating Lease, Liability, Current 343M USD -5.51%
Lessee, Operating Lease, Liability, to be Paid, Year Two 405M USD +2.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 455M USD +0.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 960M USD -1.64%
Lessee, Operating Lease, Liability, to be Paid, Year Three 344M USD +1.18%
Unrecognized Tax Benefits 504M USD -21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 281M USD -2.43%
Depreciation, Depletion and Amortization 3.31B USD +7.64%
Deferred Tax Assets, Net of Valuation Allowance 1.87B USD -15.7%
Interest Expense 2.06B USD +6.35%